Zevra Therapeutics, Inc. ZVRA Inventory write-downs
Inventory write-downs at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryWriteDown.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s inventory write-downs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s inventory write-downs?
- Zevra Therapeutics, Inc. (ZVRA) reported inventory write-downs of $485K in Q1 2026.
- What does inventory write-downs mean?
- Represents the non-cash charge taken to reduce the carrying value of inventory when its market value falls below cost or it becomes obsolete. This metric highlights potential inefficiencies in supply chain management or shifts in product demand that may impact future profitability.